Mirabella Financial Services LLP Cogent Biosciences, Inc. Transaction History

Mirabella Financial Services LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$10.04 - $15.5 $292,666 - $451,825	-29,150 Reduced 24.14%	91,617 $988,000
Q4 2022 Feb 13, 2023	BUY	$10.65 - $14.84 $1.29 Million - $1.79 Million	120,767 New	120,767 $1.4 Million
Q1 2021 May 17, 2021	SELL	$7.47 - $12.34 $216,032 - $356,872	-28,920 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.04 - $13.01 $261,436 - $376,249	28,920 New	28,920 $325,000

172

114M

56.7K

40.4K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $528M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

Stay updated on Mirabella Financial Services LLP with notifications on news.